Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Sodium labeling

This article was originally published in The Tan Sheet

Executive Summary

Sodium labeling: FDA is postponing the effective date of the sodium labeling final rule for OTCs intended for oral ingestion, except for products containing sodium bicarbonate, sodium phosphate or sodium biphosphate, to match that of the calcium, magnesium and potassium labeling final rule. The calcium, magnesium and potassium labeling final rule is expected to be published in the Federal Register "in the near future" and will be effective a year afterward. The delay is in response to requests that the two dates be the same. Both rules call for label content and warnings for products containing specified amounts of the substances. The sodium rule was published a year ago ("The Tan Sheet" April 29, 1996, p. 8)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086968

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel